Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer Europe OTC Drugs

CHPA, CTFA Urge OTC Sale Of Tooth Whiteners In Europe

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Tooth whitening products containing 6% hydrogen peroxide should be sold over the counter in Europe, the Consumer Healthcare Products Association and Cosmetic, Toiletry & Fragrance Association maintain in joint comments to the European Commission

You may also be interested in...



SCCP Upholds Opinion On Tooth Whiteners With Hydrogen Peroxide

Adequate data do not exist to support the safety of tooth-whitening products containing up to 6% hydrogen peroxide for over-the-counter use, the European Commission Scientific Committee on Consumer Products concludes in a recent opinion

SCCP Upholds Opinion On Tooth Whiteners With Hydrogen Peroxide

Adequate data do not exist to support the safety of tooth-whitening products containing up to 6% hydrogen peroxide for over-the-counter use, the European Commission Scientific Committee on Consumer Products concludes in a recent opinion

SCCP Upholds Opinion On Tooth Whiteners With Hydrogen Peroxide

Adequate data do not exist to support the safety of tooth-whitening products containing up to 6% hydrogen peroxide for over-the-counter use, the European Commission Scientific Committee on Consumer Products concludes in a recent opinion

Table

View full table

Topics

Tags:
Consumer Europe OTC Drugs
Latest Headlines

National Drug Stockpiles Create ‘False Sense Of Security’

Patent Office Issues Proposed Rule For Rarely Successful Director Review Requests

Medicare Spending Forecast For Leqembi Reflects CMS Angst About Alzheimer’s Drug Costs

US FDA Drugs Center Launches Clinical Trial Innovation Hub With Demonstration Projects

See All
UsernamePublicRestriction

Register

PS097815

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By